Beta-2 Microglobulin (B2M)

Catalogue Number: 126-11
Availability Discontinued; Replaced with 126-15
Product Name Beta-2 Microglobulin
Source Human Urine
Catalogue Number 126-11
Purity > 98% (SDS-PAGE)
Form Lyophilized
Protein Reported in mg/vial (E0.1%280 nm=1.65)
Formulation Lyophilized from 0.02 M ammonium bicarbonate. May contain traces of buffer salts.
Appearance White powder
Reconstitution Phosphate buffered saline, pH >7.0
Related Products GB2-80A - anti-Human B2M polyclonal antibody
126-12 - B2M antigen from human urine - Liquid
431-11 - Myoglobin antigen from human heart
Storage 2-8°C
Recertification 5 years
Infectious Disease Testing Negative or non-reactive at the donor level for anti-HIV 1 and 2, anti-HCV, HBsAg, and syphilis by FDA approved methods.
Molecular Weight ~12,000
Synonyms B2M, BMG
UNSPSC code 51131907
Gene B2M, CDABP0092, HDCMA22P
Gene ID 567
Accession No P61769
References Nature Medicine volume 21, pages 932–937 (2015)

Lee Biosolutions is the leading producer and supplier of Human Urine Beta-2 Microglobulin (B2M) for use in medical autoimmune research and manufacturing of clinical diagnostic assays.

Custom preparations, technical support, bulk quantities and aliquoting available, email for more details.

Serum beta-2 Microglobulin, an endogenous marker for renal function, has been shown to be an independent predictor of mortality in older adults. The characteristics of B2M make it useful as a tumor marker for some blood cell cancers, for detecting kidney damage, and for distinguishing between glomerular and tubular disorders of the kidney. It is not diagnostic for a specific disease, but it gives the doctor additional information about someone's likely prognosis and about the health of their kidneys.

Add to Cart